Evidence map›Paper›PMID 28148533›Full record

ArticleAmerican journal of physiology. Renal physiology2017

Inhibition of vascular smooth muscle inward-rectifier K

Nathan R Tykocki, Adrian D Bonev, Thomas A Longden, Thomas J Heppner, Mark T Nelson

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Light-sensitive CaProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Review
  7. Article
  8. PIPProceedings of the National Academy of Sciences of the United States of America · 2020
    Review
  9. Review
  10. Article
  11. New therapeutic directions to treat underactive bladder.Investigative and clinical urology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Nathan R TykockiDepartment of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont; and nathan.tykocki@uvm.edu.ORCID 0000-0001-5432-7656
Adrian D BonevDepartment of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont; and.
Thomas A LongdenDepartment of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont; and.
Thomas J HeppnerDepartment of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont; and.
Mark T NelsonDepartment of Pharmacology, University of Vermont College of Medicine, Burlington, Vermont; and.
University of Vermont · US

Funding

Ca2+ Sparks and Urinary Bladder Smooth Muscle ExcitabilityR37DK053832 · NIDDK · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2008 to 2017
$3.4M
Bladder Blood Flow and Vascular Contractility Regulate Bladder FunctionK01DK103840 · NIDDK · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TYKOCKI, NATHAN ROGER · 2015 to 2019
$754k
NIDDK NIH HHS K01 DK103840NIDDK NIH HHS R37 DK053832
6 · The paper itself

Abstract

Prolonged decreases in urinary bladder blood flow are linked to overactive and underactive bladder pathologies. However, the mechanisms regulating bladder vascular reactivity are largely unknown. To investigate these mechanisms, we examined myogenic and vasoactive properties of mouse bladder feed arterioles (BFAs). Unlike similar-sized arterioles from other vascular beds, BFAs failed to constrict in response to increases in intraluminal pressure (5-80 mmHg). Consistent with this lack of myogenic tone, arteriolar smooth muscle cell membrane potential was hyperpolarized (-72.8 ± 1.4 mV) at 20 mmHg and unaffected by increasing pressure to 80 mmHg (-74.3 ± 2.2 mV). In contrast, BFAs constricted to the thromboxane analog U-46619 (100 nM), the adrenergic agonist phenylephrine (10 µM), and KCl (60 mM). Inhibition of nitric oxide synthase or intermediate- and small-conductance Ca

Indexed as

Blood PressureAnimalsArteriolesGenotypeIn Vitro TechniquesMaleMechanotransduction, CellularMembrane PotentialsMice, Inbred C57BLMice, KnockoutMuscle, Smooth, VascularMyocytes, Smooth MusclePhenotypePotassium Channel BlockersPotassium Channels, Inwardly RectifyingUrinary BladderKir2.1 channelPotassium Channel BlockersPotassium Channels, Inwardly RectifyingVasoconstrictor AgentsVasodilator Agentsmyogenic tonepotassium channelsurinary bladdervasculature

Identifiers

PMID28148533
PMCPMC5451557
OpenAlexW2585923040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.